Pepose Jay 4
4 · Ocuphire Pharma, Inc. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
Pepose Jay
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-07+40,000→ 40,000 totalExercise: $5.74Exp: 2031-06-07→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Will vest in a series of three successive equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continuing service through each applicable vesting date.